Categories: Wire Stories

Dr. Reddy’s Laboratories Announces First-to-Market Launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe, a therapeutic equivalent generic version of Narcan® (naloxone hydrochloride) Injection USP, approved by the U.S. Food and Drug Administration (USFDA).

“We are pleased to bring our second product to market that has been designated as a Competitive Generic Therapy (CGT) by the USFDA,” says Marc Kikuchi, Chief Executive Officer, North America Generics, Dr. Reddy’s Laboratories. “With a CGT designation, we have 180-day CGT exclusivity to market this product.”

The Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) had U.S. sales of approximately $31 million MAT for the most recent twelve months ending in January 2020 according to IQVIA Health*.

Dr. Reddy’s Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) is available in 2 mL single-dose prefilled syringe.

Please see full prescribing information.

https://www.drreddys.com/pi/Naloxone_Hydrochloride_Injection_PI.pdf

NARCAN® is a trademark of ADAPT Pharma Operations Limited

*IQIA Retail and Non-Retail MAT January 2020

RDY-0320-282

About Dr. Reddy’s: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses – Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, India, Russia & CIS countries, and Europe. For more information, log on to:www.drreddys.com

Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the management’s current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words “may”, “will”, “should”, “expects”, “plans”, “intends”, “anticipates”, “believes”, “estimates”, “predicts”, “potential”, or “continue” and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates , interest rates , persistency levels and frequency / severity of insured loss events (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization , including related integration issues.

The company assumes no obligation to update any information contained herein.

 

Contacts

INVESTOR RELATIONS
AMIT AGARWAL

amita@drreddys.com
(PH: +91-40-49002135)

MEDIA RELATIONS
APARNA TEKURI

aparnatekuri@drreddys.com
(PH: +91-40- 49002446)

Alex

Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.

Recent Posts

Earth’s Temporary Mini-Moon Obscures the Shift Toward Permanent Lunar Settlements

The real significance of Earth's temporary second satellite isn't the fleeting spectacle of an asteroid…

53 minutes ago

ACT Fibernet Launches Stream TV 4K Box as Digital Networks Expand Live Content Options

ACT Fibernet has launched its Stream TV 4K device in India, expanding its consumer product…

2 hours ago

Real Madrid Seeks Dominance at Granada Across Men’s and Women’s Campaigns

Maintaining momentum across distinct domestic competitions is rarely about raw talent alone; it is about…

3 hours ago

Actor Alexander Haskin Dead at 38 After Jump From Santa Monica Pier

Police in Southern California identified 38-year-old background actor Alexander Haskin as the man who died…

4 hours ago

Baroda Elects to Field as Bengal Reaches 166/6 in Syed Mushtaq Ali Trophy Clash

Baroda won the toss and elected to field against Bengal in Match 85 of the…

6 hours ago

Leandro Paredes collapses live on TV after Boca title, then faces FIFA 10-match ban

Leandro Paredes collapsed during a live television interview after Boca Juniors became Copa Sudamericana champions.…

7 hours ago